PCR Perspectives

What does it take to ensure a smooth, safe, and confident discharge for TAVI patients? Sarah Carson and Gemma McCalmont share valuable insights and practical strategies. From pre-assessment planning and early mobilization to managing complications and preparing patients for recovery, this video offers essential tips for streamlining the discharge process! Hosted on Acast. See acast.com/privacy for more information.

Curious about the latest advancements in transcatheter tricuspid valve interventions? Don't miss this discussion between Philipp Lurz and Lukas Stolz at PCR London Valves 2024! They delve into the topic of residual tricuspid regurgitation after transcatheter repair—a challenge that still needs improvement despite significant progress. Hosted on Acast. See acast.com/privacy for more information.

Wondering which is the better option for female patients—SAVR or TAVR? Don’t miss this exchange between Hendrik Treede and Hélène Eltchaninoff. They explore the unique challenges and nuances of valve interventions for women, highlighting evolving strategies to optimize treatment and improve outcomes. Hosted on Acast. See acast.com/privacy for more information.

Curious about the specific considerations for TAVI in women? Martine Gilard and Dan Blackman highlight the challenges women face in the diagnosis and treatment of aortic stenosis (underrepresentation, later presentation, undertreatment...) while exploring key anatomical differences (smaller aortic anatomy, less calcification...), and how these factors impact diagnostic thresholds, imaging and valve selection. Hosted on Acast. See acast.com/privacy for more information.

How do we navigate the thin line between bleeding risk and thrombosis in high-risk patients undergoing tricuspid valve interventions? Marianna Adamo and Fabien Praz explore the latest strategies in anticoagulation, the challenges of managing complex cases and how cutting-edge research is shaping the future of care. Listen to this podcast to discover the keys to optimizing outcomes in this rapidly evolving field! Hosted on Acast. See acast.com/privacy for more information.

What is the optimal TAVI access approach in today’s practice? In this conversation at PCR London Valves 2024, Ole De Backer and Maarten Vanhaverbeke break down the latest evidence and trends in TAVI access. Listen to this podcast to learn about the dominance of transfemoral access, the role of alternative routes like transcarotid and transaxillary, the growing use of cutting-edge tools like intravascular lithotripsy and orbital atherectomy, and much more! Hosted on Acast. See acast.com/privacy for more information.

Elliot Smith, Thomas Hovasse, and Roberto Garbo present a structured, step-by-step approach to chronic total occlusion (CTO) interventions, starting from angiographic analysis through to strategy selection and technique adaptation.The discussion begins with angiographic assessment, emphasising the importance of identifying key anatomical features upfront. Based on this evaluation, operators determine the most appropriate strategy—typically beginning with an antegrade approach, with readiness to escalate to retrograde or dissection techniques depending on case complexity and progression.The panel outlines essential tools for CTO procedures, including a 7 Fr guiding catheter, various wires (from soft to stiff), and microcatheters, while also addressing how these tools are introduced into routine practice. Attention is given to operator experience, decision-making flexibility, and technique sequencing.In parallel, the importance of progressive skill acquisition is highlighted. Failure is positioned not as an endpoint, but as a learning opportunity—integral to refining technique and gaining confidence.Listen to this discussion for structured guidance on navigating CTOs in a safe and effective way. Hosted on Acast. See acast.com/privacy for more information.

In this #europcr 2025 exchange, Ole De Backer and Philippe Garot explore the evolving landscape of transcatheter left atrial appendage (LAA) occlusion. From differences in patient selection on either side of the Atlantic—high bleeding risk in Europe vs. broader indications in the US—to upcoming pivotal trials comparing LAA closure to DOACs, this conversation covers it all.They also break down what defines a state-of-the-art LAA procedure, with an emphasis on pre-procedural imaging (cardiac CT or 3D TEE), and share key insights on post-procedural management, including antithrombotic therapy and follow-up imaging.Hit play for a quick yet comprehensive update on where LAA closure is headed. Hosted on Acast. See acast.com/privacy for more information.

Cleverson Zukowski and Pablo Lamelas take a moment during #europcr 2025 to shed light on a major regional milestone: the first-ever guidelines for the treatment of left main disease, issued jointly by the Latin American Society of Interventional Cardiology (SOLACI) and the Interamerican Society of Cardiology (SIAC). Why were these guidelines created specifically for Latin America? What are their key recommendations? And how can they be applied in day-to-day practice, especially when deciding between PCI and surgery?Tune in to hear how these guidelines reflect the region’s unique healthcare challenges and may help tailor treatment to the specific needs of Latin American patients. Hosted on Acast. See acast.com/privacy for more information.

Stephan Windecker and Flavio Ribichini review the outcomes of the FAITAVI trial, presented during the #europcr 2025 LBT session.As coronary artery disease is the most common cardiac comorbidity in patients undergoing TAVI, the trial set out to evaluate whether physiology-guided decision-making could offer better clarity.When performing diagnostic angiography before TAVI, clinicians often find intermediate coronary lesions that don’t obviously require revascularisation — so what's the right strategy in these cases?FAITAVI is the first randomised trial comparing angiography-guided versus FFR-guided PCI decisions in the TAVI setting. Learn more about the study design, inspired by FAME-1, and how the results support the feasibility and value of FFR measurements in patients with CAD undergoing TAVI. The data also confirm that intermediate lesions can safely be left untreated.Listen to this episode now to understand how these findings could change practice! Hosted on Acast. See acast.com/privacy for more information.

What does the PREVENT trial tell us about managing vulnerable plaques? Recorded during #europcr 2025, this discussion features Michael Haude and Thomas Cuisset as they review key insights from this major study of over 1,600 patients with physiologically non-significant but vulnerable plaques identified by intracoronary imaging—mainly IVUS. Patients were randomised to receive either optimal medical therapy (OMT) alone or combined with preventive PCI, and followed over several years. While the composite endpoint favored the PCI group, the benefit was driven solely by a reduction in target lesion revascularisation—without differences in death or myocardial infarction. Should PCI be systematically performed in such cases? Tune in for a nuanced expert perspective! Hosted on Acast. See acast.com/privacy for more information.

Nicola Ryan and Flavio Ribichini discuss the challenges of treating the calcified left main stem. They break down the complexities of this high-risk condition and highlight the role of mechanical circulatory support in everyday practice. They focus on the role of intracoronary imaging as a game-changer and examine the use of one versus two stents, outlining cases where two stents may be necessary.Key takeaways1. Calcified left main stem disease is complex but can be simplified with the right tools.2. Intravascular imaging is crucial for accurate assessment and treatment planning.3. A careful, step-by-step approach leads to the best angiographic results. Hosted on Acast. See acast.com/privacy for more information.

At #EuroPCR2025, Martine Gilard, Antonio Mangieri, and Marco Barbanti share their perspectives on managing coronary artery disease in patients scheduled for TAVI. Is coronary angiography always necessary? When should PCI be performed—before, during, or after the procedure? And how do you decide? Tune in for a practical exchange on strategy, timing, and patient selection! Hosted on Acast. See acast.com/privacy for more information.

In this exchange, Vijay Kunadian and Javier Escaned explore the real-world implementation of INOCA (Ischemia with Non-Obstructive Coronary Arteries) and ANOCA (Angina with Non-Obstructive Coronary Arteries) diagnostic pathways. Drawing on the 2024 CCS (Chronic Coronary Syndromes) guidelines, and the EAPCI consensus document, they discuss why these conditions remain underdiagnosed—and how structured invasive assessment can make a difference, even in time-constrained clinical environments.This conversation offers practical insights for improving patient care by refining diagnosis and treatment strategies in cases where traditional imaging may fall short. Hosted on Acast. See acast.com/privacy for more information.

How effective is cerebral protection during TAVI?Bernard Prendergast and Rajesh Kharbanda take a deep dive into this key procedural question, reviewing the latest evidence from two major randomised trials—PROTECTED TAVR and BHF PROTECT-TAVI.Although both studies individually failed to demonstrate a clinical benefit for cerebral protection devices, a new patient-level meta-analysis presented at #EuroPCR2025 offers fresh insights.Listen to this episode now to understand how aligning endpoints and patient profiles has helped uncover new signals that could shape future practice. Hosted on Acast. See acast.com/privacy for more information.